IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $299,507 | -45.9% | 37,345 | +0.0% | 0.03% | -44.1% |
Q1 2024 | $553,438 | +86.1% | 37,344 | +2.1% | 0.06% | +68.6% |
Q4 2023 | $297,347 | +81.6% | 36,574 | +1.6% | 0.04% | +66.7% |
Q3 2023 | $163,782 | -34.3% | 35,996 | +1.6% | 0.02% | -34.4% |
Q2 2023 | $249,392 | +13.3% | 35,425 | -1.7% | 0.03% | 0.0% |
Q1 2023 | $220,137 | +15.1% | 36,029 | +20.4% | 0.03% | +6.7% |
Q4 2022 | $191,291 | +35.2% | 29,936 | +102.7% | 0.03% | +15.4% |
Q3 2022 | $141,458 | -42.3% | 14,766 | -33.5% | 0.03% | -42.2% |
Q2 2022 | $245,187 | -53.9% | 22,209 | +106.2% | 0.04% | -47.7% |
Q1 2022 | $531,558 | -3.2% | 10,769 | +0.1% | 0.09% | -4.4% |
Q4 2021 | $549,400 | -1.1% | 10,762 | +0.2% | 0.09% | -10.0% |
Q3 2021 | $555,250 | -0.2% | 10,744 | +0.1% | 0.10% | +5.3% |
Q2 2021 | $556,291 | -6.5% | 10,733 | -6.6% | 0.10% | -12.8% |
Q1 2021 | $594,849 | -12.9% | 11,488 | -12.1% | 0.11% | -11.4% |
Q4 2020 | $682,568 | -3.3% | 13,071 | -3.4% | 0.12% | -14.0% |
Q3 2020 | $705,548 | – | 13,537 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
CM Management, LLC | 200,000 | $910,000 | 0.97% |
Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |